The committee of Aurobindo Pharma in its meeting on 12 March 2010 has allotted 4,03,138 equity shares of Rs. 5 each for cash at a premium of Rs. 517.036 by conversion of bonds worth US$ 48,50,000 in terms of the offer document to the FCCB holders.
Consequent to the aforesaid allotment, the paid up capital of the company has gone up from 5,53,25,699 equity shares of Rs. 5 each to 5,57,28,837 equity shares of Rs. 5 each and the outstanding FCCBs for the issue of USD$ 60 million convertible bonds due in 2010 is now at US$ 31.78 million.